Shared genetics and bidirectional causal relationships between type 2 diabetes and attention-deficit/hyperactivity disorder

Background Type 2 diabetes (T2D) is a chronic metabolic disorder with high comorbidity with mental disorders. The genetic links between attention-deficit/hyperactivity disorder (ADHD) and T2D have yet to be elucidated. Aims We aim to assess shared genetics and potential associations between ADHD and T2D. Methods We performed genetic correlation, two-sample Mendelian randomisation and polygenic overlap analyses between ADHD and T2D. The genome-wide association study (GWAS) summary results of T2D (80 154 cases and 853 816 controls), ADHD2019 (20 183 cases and 35 191 controls from the 2019 GWAS ADHD dataset) and ADHD2022 (38 691 cases and 275 986 controls from the 2022 GWAS ADHD dataset) were used for the analyses. The T2D dataset was obtained from the DIAGRAM Consortium. The ADHD datasets were obtained from the Psychiatric Genomics Consortium. We compared genome-wide association signals to reveal shared genetic variation between T2D and ADHD using the larger ADHD2022 dataset. Moreover, molecular pathways were constructed based on large-scale literature data to understand the connection between ADHD and T2D. Results T2D has positive genetic correlations with ADHD2019 (rg=0.33) and ADHD2022 (rg=0.31). Genetic liability to ADHD2019 was associated with an increased risk for T2D (odds ratio (OR): 1.30, p<0.001), while genetic liability to ADHD2022 had a suggestive causal effect on T2D (OR: 1.30, p=0.086). Genetic liability to T2D was associated with a higher risk for ADHD2019 (OR: 1.05, p=0.001) and ADHD2022 (OR: 1.03, p<0.001). The polygenic overlap analysis showed that most causal variants of T2D are shared with ADHD2022. T2D and ADHD2022 have three overlapping loci. Molecular pathway analysis suggests that ADHD and T2D could promote the risk of each other through inflammatory pathways. Conclusions Our study demonstrates substantial shared genetics and bidirectional causal associations between ADHD and T2D.

[1]  A. Baranova,et al.  Shared genetics and causal associations between COVID‐19 and multiple sclerosis , 2022, Journal of medical virology.

[2]  A. Baranova,et al.  A phenome‐wide investigation of risk factors for severe COVID‐19 , 2022, Journal of medical virology.

[3]  M. Ren,et al.  Psychiatric disorders and Type 2 diabetes mellitus: A bidirectional Mendelian randomization , 2022, European journal of clinical investigation.

[4]  L. Cai,et al.  Investigating genetic causal relationships between blood pressure and anxiety, depressive symptoms, neuroticism and subjective well-being , 2022, General Psychiatry.

[5]  Bin Zhang,et al.  Handgrip strength and the risk of major depressive disorder: a two-sample Mendelian randomisation study , 2022, General Psychiatry.

[6]  Lin Qiu,et al.  Association of gestational diabetes mellitus with overall and type specific cardiovascular and cerebrovascular diseases: systematic review and meta-analysis , 2022, BMJ.

[7]  A. Baranova,et al.  Bidirectional causal associations between type 2 diabetes and COVID‐19 , 2022, Journal of medical virology.

[8]  A. Baranova,et al.  Genetic Relationships between Attention-Deficit/Hyperactivity Disorder, Autism Spectrum Disorder, and Intelligence , 2022, Neuropsychobiology.

[9]  A. Baranova,et al.  Shared genetics between autism spectrum disorder and attention-deficit/hyperactivity disorder and their association with extraversion , 2022, Psychiatry Research.

[10]  P. Lichtenstein,et al.  The role of ADHD genetic risk in mid-to-late life somatic health conditions , 2022, Translational Psychiatry.

[11]  M. Daly,et al.  Genome-wide analyses of ADHD identify 27 risk loci, refine the genetic architecture and implicate several cognitive domains , 2022, European Neuropsychopharmacology.

[12]  J. Olefsky,et al.  Inflammation in obesity, diabetes, and related disorders. , 2022, Immunity.

[13]  B. Franke,et al.  Insulinopathies of the brain? Genetic overlap between somatic insulin-related and neuropsychiatric disorders , 2021, Translational Psychiatry.

[14]  Kyle J. Gaulton,et al.  Multi-ancestry genetic study of type 2 diabetes highlights the power of diverse populations for discovery and translation , 2020, Nature Genetics.

[15]  B. Duncan,et al.  IDF diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045 , 2021, Diabetes Research and Clinical Practice.

[16]  Kenneth H. Rubin,et al.  Prevalence of type 2 diabetes in psychiatric disorders: an umbrella review with meta-analysis of 245 observational studies from 32 systematic reviews , 2021, Diabetologia.

[17]  S. Medland,et al.  Large-scale genetic investigation reveals genetic liability to multiple complex traits influencing a higher risk of ADHD , 2021, Scientific Reports.

[18]  M. Laakso,et al.  The “Common Soil Hypothesis” Revisited—Risk Factors for Type 2 Diabetes and Cardiovascular Disease , 2021, Metabolites.

[19]  C. Peixoto,et al.  Shared metabolic and neuroimmune mechanisms underlying Type 2 Diabetes Mellitus and Major Depressive Disorder , 2021, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[20]  G. Nefs,et al.  Psychiatric disorders as risk factors for type 2 diabetes: an umbrella review of systematic reviews with and without meta-analyses. , 2021, Diabetes research and clinical practice.

[21]  S. Larsson,et al.  Genetically predicted education attainment in relation to somatic and mental health , 2021, Scientific Reports.

[22]  C. Lavebratt,et al.  Proinflammatory mediators and their associations with medication and comorbid traits in children and adults with ADHD , 2020, European Neuropsychopharmacology.

[23]  Fuquan Zhang,et al.  Multi-trait analysis for genome-wide association study of five psychiatric disorders , 2020, Translational Psychiatry.

[24]  M. Gissler,et al.  Relationship of prenatal maternal obesity and diabetes to offspring neurodevelopmental and psychiatric disorders: a narrative review , 2020, International Journal of Obesity.

[25]  Fuquan Zhang,et al.  Identifying common genome-wide risk genes for major psychiatric traits , 2019, Human Genetics.

[26]  Alicia R. Martin,et al.  Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder , 2018, Nature Genetics.

[27]  Valeriia Haberland,et al.  The MR-Base platform supports systematic causal inference across the human phenome , 2018, eLife.

[28]  Evangelos Evangelou,et al.  Risk factors for type 2 diabetes mellitus: An exposure-wide umbrella review of meta-analyses , 2018, PloS one.

[29]  S. Djurovic,et al.  Bivariate causal mixture model quantifies polygenic overlap between complex traits beyond genetic correlation , 2017, bioRxiv.

[30]  D. Posthuma,et al.  Functional mapping and annotation of genetic associations with FUMA , 2017, Nature Communications.

[31]  M. Daly,et al.  LD Score regression distinguishes confounding from polygenicity in genome-wide association studies , 2014, Nature Genetics.

[32]  E. Willcutt.  The Prevalence of DSM-IV Attention-Deficit/Hyperactivity Disorder: A Meta-Analytic Review , 2012, Neurotherapeutics.

[33]  Michael Fitzgerald,et al.  European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD , 2010, BMC psychiatry.

[34]  Michael Boehnke,et al.  LocusZoom: regional visualization of genome-wide association scan results , 2010, Bioinform..

[35]  Sergei Egorov,et al.  Pathway studio - the analysis and navigation of molecular networks , 2003, Bioinform..